Scarica l'app Stockscreener
37.77
5.57%
-2.23
Dopo l'orario di chiusura:
38.25
0.48
+1.27%
Terns Pharmaceuticals Inc Borsa (TERN) Ultime notizie
How Rhythm Pharmaceuticals, Inc. stock performs during market volatility - ulpravda.ru
Tern Pharmaceuticals (TERN) soars 630% on CML treatment best-in-class potential - MSN
Terns Pharmaceuticals (TERN) price target increased by 75.91% to 54.63 - MSN
Why Terns Pharmaceuticals Inc. stock could see breakout soonEarnings Beat & Consistent Return Investment Signals - ulpravda.ru
Why Terns Pharmaceuticals Inc. stock could be next big winnerEarnings Recap Summary & Daily Entry Point Trade Alerts - ulpravda.ru
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference - TradingView — Track All Markets
Daily News - FinancialContent
Terns Pharmaceuticals CMO Kuriakose sells $44,552 in stock - Investing.com
Terns Pharmaceuticals CEO Burroughs sells $2.7m in shares By Investing.com - Investing.com Nigeria
Terns Pharmaceuticals CEO Burroughs sells $2.7m in shares - Investing.com
With 53% Institutional Ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Is a Favorite Amongst the Big Guns - 富途牛牛
Terns Pharmaceuticals reports inducement grants to new employees under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Terns Pharmaceuticals Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Tern Pharmaceuticals (TERN) Soars 630% on CML Treatment Best-in-Class Potential - Insider Monkey
Meet the 10 Market Stars Behind Millionaire-Making in 2025 - Insider Monkey
Terns Pharmaceuticals Earnings Notes - Trefis
The biggest end-of-year sale in the Bay Area was for $4 billion in biotech stockSan Francisco Business Times - The Business Journals
12 Overlooked Stocks That Delivered Massive Gains In 2025 - RTTNews
Terns Pharmaceuticals stock slides today, testing the $40 level after December share sale - ts2.tech
Terns Pharmaceuticals stock soars after leukemia drug delivers big early responses in tough-to-treat patients - MSN
Pharmaceutical Stocks To Follow TodayDecember 10th - MarketBeat
Terns Pharmaceuticals proposes $400M equity offering - MSN
Terns Pharmaceuticals (TERN) climbs 53% on stellar leukemia treatment trial - MSN
Truist Securities maintains Terns Pharmaceuticals (TERN) buy recommendation - MSN
Terns Pharmaceuticals (TERN) Is Down 7.7% After Strong TERN-701 Phase 1 DataHas The Bull Case Changed? - Sahm
Jim Cramer highlights massive gains for Terns Pharmaceuticals shareholders - MSN
Terns Pharmaceuticals (TERN) Price Target Increased by 75.91% to 54.63 - Nasdaq
Will Terns Pharmaceuticals Inc. stock gain from government policies2025 Bull vs Bear & Weekly High Potential Alerts - moha.gov.vn
How Terns Pharmaceuticals Inc. stock performs in weak economyEarnings Performance Report & High Conviction Trade Alerts - Улправда
Is Terns Pharmaceuticals Inc. stock attractive for long term wealth buildingJobs Report & Target Return Focused Stock Picks - Улправда
Jim Cramer Highlights Massive Gains for Terns Pharmaceuticals Shareholders - Finviz
Terns Pharmaceuticals unveils promising phase 1 trial data - MSN
Insider Trends: How Terns Pharmaceuticals Inc. stock performs in weak economyJuly 2025 Volume & Free Expert Approved Momentum Trade Ideas - Улправда
Is Terns Pharmaceuticals Inc. stock a contrarian buy2025 Price Momentum & Free High Accuracy Swing Entry Alerts - Улправда
Terns Pharmaceuticals (TERN) Stock Today (Dec. 18, 2025): Why Shares Are Sliding After the Rally, and What Analysts Forecast Next - ts2.tech
Jim Cramer Was Asked About These 11 Stocks - Insider Monkey
Operating cash flow per share of Terns Pharmaceuticals, Inc. – GETTEX:430 - TradingView — Track All Markets
Terns Pharmaceuticals (TERN) Stock Today: Latest News, Analyst Forecasts, and What to Watch (December 16, 2025) - ts2.tech
Terns Pharmaceuticals (TERN): Valuation Check After Strong CARDINAL Trial Data for CML Candidate TERN-701 - simplywall.st
Terns Pharmaceuticals, Inc. (TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid LeukemiaSlideshow (NASDAQ:TERN) 2025-12-15 - Seeking Alpha
Terns CEO Amy Burroughs talks cancer drug trial win - CNBC
Biotech ETF SBIO Hovers Near Peak on Rally - ETF Database
Terns Pharmaceuticals raises $747.5 million in upsized offering - Traders Union
Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial - Finviz
10 Stocks Delivering Explosive 18-190% Gains - Insider Monkey
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):